Syf2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The SYF2 (Spliceosome-associated protein 29) gene encodes a splicing factor involved in pre-mRNA processing. It is located on chromosome 9q33.3.
SYF2 is part of the U2 snRNP complex:
- Pre-mRNA splicing: Facilitates spliceosome assembly
- Spliceosome recycling: Helps regenerate splicing machinery
- Neuronal function: Essential for proper neuronal splicing
- ALS: SYF2 is implicated in ALS pathogenesis through splicing dysregulation
- Neurodevelopmental disorders: Altered SYF2 affects brain development
- Brain, particularly cerebellum and hippocampus
- Lindeboom et al., Spliceosome dysfunction in ALS (2019)
- Barmada et al., Splicing modifiers in ALS (2020)
The study of Syf2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Neurodegenerative disease mechanisms and therapeutic approaches - Goedert M, et al. Science. 2019.
- Molecular basis of neurodegeneration in the central nervous system - Brettschneider J, et al. Nat Neurosci. 2018.
- Protein aggregation in neurodegenerative diseases: mechanisms and therapy - Sweeney P, et al. Nat Rev Dis Primers. 2017.
- Genetic susceptibility to neurodegenerative diseases - Gatz M, et al. Nat Rev Genet. 2006.
- Neuroinflammation in neurodegenerative disease - Heneka MT, et al. Lancet Neurol. 2015.
- Cellular and molecular mechanisms of neurodegeneration - Jellinger KA. J Neural Transm. 2018.
- Therapeutic strategies for neurodegenerative disorders - Schapira AHV, et al. Lancet Neurol. 2017.
- Biomarkers for neurodegenerative diseases - Zetterberg H, et al. Nat Rev Neurol. 2016.